Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $32.69 million as of November 19, 2026. It is the 33,201st most valuable company in the world and the 4,841st biggest in the United States. Its market cap has decreased by 27.68% in one year.
Market Cap
32.69M
Enterprise Value
-25.30M
1-Year Change
-27.68%
Global Rank
Country Rank
#4,841 United States
Category
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $32.69M, a decrease of -83.11%. That is a compound annual growth rate of -18.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 39.80M | 65.83% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 23.84M |
| Lite Strategy | 23.75M |
| GridAI Technologies | 23.37M |
| BeyondSpring | 23.02M |
| Immutep | 22.86M |
| CervoMed | 22.69M |
| IGC Pharma | 21.93M |
| Cocrystal Pharma | 19.46M |